Finding the best shield: vaccine trial aims to protect vulnerable patients from deadly meningitis
NCT ID NCT04166656
Summary
This study aims to find the best way to protect adults without a spleen from a severe bacterial infection called meningococcus B. It will compare the safety and immune response of three different vaccination schedules using two approved vaccines. The goal is to provide clear guidance on how to best vaccinate this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPLENECTOMY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
I-REIVAC/CIC1417 Cochin Hospital, AP-HP
RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.